Francesc Bosch
125 years of experience
4.4
6 reviews
- Specializes in immunotherapy with Keytruda for lymphoproliferative disorders.
- Trained in the USA at Columbia University's Institute of Cancer Genetics.
- Leads clinical trials advancing Keytruda treatment methodologies.
- Member of the Spanish group for CLL study (GELLC).
- Published over 100 articles, including on new therapies like Keytruda.



